Home > Insider Trading > Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd (TAK)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

12 Most Profitable Pharmaceutical Stocks Right Now

Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...

Keep Reading →

November 29th, 2024 - Hedge Funds News

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2025 Earnings Call Transcript

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2025 Earnings Call Transcript October 31, 2024Takeda Pharmaceutical Company Limited beats earnings expectations.

Keep Reading →

November 2nd, 2024 - News Transcripts

10 Best Japanese Stocks To Buy Now

As we navigate through 2024, Japan’s economic landscape is emerging as a compelling arena for investors. Despite facing a rough start to the year, the nation is showing signs of a promising rebound.

Keep Reading →

September 20th, 2024 - Hedge Funds News

10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers

The pharmaceutical industry is one of the most interesting sectors to invest in.

Keep Reading →

August 27th, 2024 - News Quantitative Investing

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q1 2025 Earnings Call Transcript

Christopher O’Reilly: Thank you very much for taking time out of your very busy schedule to join us for this first quarter earnings call by Takeda for FY ‘24. I’m the master of ceremony today.

Keep Reading →

August 5th, 2024 - News Transcripts

20 Fastest Growing Health Tech Companies in the World

In this article, we will be taking a look at the 20 fastest growing health tech companies in the world.

Keep Reading →

April 25th, 2024 - Lists News

5 Best Japanese Stocks To Buy In 2024

Takeda Pharmaceutical Company Limited (NYSE:TAK) is a global pharmaceutical company engaged in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products.

Keep Reading →

February 24th, 2024 - News